MENU

Wizbiotech Boosts Pharmacy Revenue with In-Store Fingerstick POCT Testing via 3-in-1 Immunoassay Analyzer for HbA1c, Vitamin D, and Ferritin

Xiamen Wiz Biotech Co., Ltd. China
Overview
Wizbiotech is promoting its 3-in-1 POCT immunoassay analyzer for in-store fingerstick testing in pharmacies globally, offering accurate quantitative HbA1c, Vitamin D, and Ferritin testing. This solution enables pharmacies to offer high-margin health screening services, attracting customers and complying with local regulatory standards across various regions. The initiative reflects a shift towards community-based preventive healthcare, allowing patients fast and reliable screening without hospital queues.
In Depth

Key Findings

Xiamen Wiz Biotech Co., Ltd. (Wizbiotech) is deploying its 3-in-1 immunoassay analyzer across global markets, enabling pharmacies to expand revenue streams by offering in-store fingerstick point-of-care testing (POCT) for accurate quantitative measurement of HbA1c, Vitamin D, and Ferritin. This innovative solution empowers pharmacies to provide new, high-margin healthcare services, attract more customers, and comply with local regulatory standards. It represents an acceleration of the shift towards community-based preventive healthcare, allowing patients to receive rapid and reliable health screenings without hospital wait times.

Technical & Clinical Details

  • 3-in-1 POCT Immunoassay Analyzer: Wizbiotech’s analyzer can measure three crucial biomarkers within a single device:
    • HbA1c (Hemoglobin A1c): A key indicator for diabetes management, reflecting average blood glucose control over the past 2-3 months. Essential for diabetes screening, diagnosis, and management.
    • Vitamin D: A vital nutrient playing significant roles in bone health, immune function, and mood regulation. Vitamin D deficiency screening is recommended, especially for the elderly and individuals with limited sun exposure.
    • Ferritin: A protein reflecting the body’s iron stores. Used for diagnosing anemia and monitoring iron deficiency.

    These biomarkers are measured rapidly and accurately from a small fingerstick blood sample, with results available within minutes.

  • Quantitative Measurement and High Precision: The device provides not only qualitative detection but also quantitative measurements, enabling physicians and pharmacists to make diagnoses and offer advice based on specific numerical values. This facilitates the development of more personalized treatment plans.
  • User-Friendly Design: The analyzer features an intuitive interface and simple operational procedures, making it easy for pharmacists and trained staff in pharmacies to operate. It requires no specialized expertise or complex laboratory equipment, and placement constraints are minimal.
  • Regulatory Compliance: Designed to comply with medical device regulations in various countries (e.g., CE Mark, FDA approval), it provides a solid foundation for confident adoption in pharmacies worldwide.

Background & Industry Context

Globally, healthcare systems are facing increasing burdens, a rising prevalence of chronic diseases, and an accelerating shift towards preventive medicine. In this context, pharmacies are expanding their role from mere drug dispensing points to accessible community healthcare hubs. POCT offers patients the opportunity to quickly assess their health status within their community, without needing to visit specialized facilities, thereby promoting early disease detection and intervention. The adoption of POCT in pharmacies is a strategic move that not only enhances patient convenience but also diversifies revenue streams and strengthens the competitiveness of pharmacies themselves.

Strategic Significance & Outlook

Wizbiotech’s 3-in-1 POCT immunoassay analyzer has the potential to revolutionize pharmacy business models and deepen their contribution to public health. In the future, expanding the range of measurable biomarkers and integrating AI-powered data analysis could enable even more sophisticated personalized health advice. Furthermore, if integration with telemedicine systems and expanded insurance coverage advance, in-pharmacy POCT testing could become more widespread, solidifying the pharmacy’s role as a core component of local healthcare. This is expected to accelerate patient-centric preventive medicine and contribute to overall healthcare cost optimization.

Source: https://www.wizbiotech.com/news/product-news/expand-pharmacy-revenue-with-in-store-fingerstick-poct-testing_a84

Get our weekly technology intelligence — free

Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.

Subscribe Free — Weekly Tech Intelligence

By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.

  • Your email and selected fields are used only to deliver the newsletter.
  • We never share your information with third parties.
  • You can unsubscribe anytime via the link in each email.

See our Privacy Policy for details.

Takes about a minute · Unsubscribe anytime

Let's share this post !

Author of this article

Comments

To comment

TOC